FEATURED SLIDESHOW
Who Is The Worst CEO?Mad Money needed new inductees for its
Wall of Shame, so we asked viewers for
nominations.
RECENT POSTS
- Money-Making Mood Stabilizers
- No Product Revenues, Plenty of Risk: Buy Exelixis?
- Lightning Round: Caterpillar, Starbucks, Intel and More
- Lightning Round OT: SanDisk, Marvel Entertainment and More
- The Discounter’s Dilemma
- Cramer: Earnings, IPOs Dominate Next Week’s Game Plan
- Cramer: GE Upgrade 'Very Powerful'
- 2 Takeover Targets in the Pharma Market
- Lightning Round: Bank of America, Crocs, Inergy and More
- Lightning Round OT: Royal Bank of Scotland, Seabridge Gold and More


On Friday’s Game Plan, Cramer advised Homegamers to take a moment this weekend to make a shopping list by writing down the companies – not the stocks – they want to own a piece of along with the price they would be willing to pay. Take ConocoPhillips [COP
Loading...
()
], Cramer’s favorite oil name. Last week COP hit $69. Two days later it was at $76. Without a list and a price ready, it would have been easy to hold off buying until COP went lower than $69. But it never did.
So what could be next week’s Conoco? Cramer recommended Procter & Gamble [PG
Loading...
()
], down 12 points from its high and a great place to start a position, he said. There’s also Altria [MO
Loading...
()
] at $73 with a 4.25% yield, less than a week from announcing plans it intends to split up. How about AT&T [T
Loading...
()
], with a 5% yield at $35?
With the Fed catching on (better late than never), some banks and homebuilders are back in play. Bear Stearns [BSC
Loading...
()
], which Cramer thinks could get taken over, is starting to look attractive down 16 points to $70. There’s also Wells Fargo [WFC
Loading...
()
] at $30 with a 5% yield. And now that the government changed the rules making it easier to get mortgage money, Toll Brothers [TOL
Loading...
()
] down at $16 is even looking good to Cramer.
The time is also right to buy Schering-Plough [SGP
Loading...
()
], he said. Shares of the drug company have been virtually cut in half on what he called “overstated” headline risk about its flagship cholesterol drug Vytorin. And in Cramer’s experience, the best time to buy drug stocks is right after the bad headlines. Think Bausch & Lomb [BOL
Loading...
()
] with its contact solution or Bristol-Myers Squib [BMY
Loading...
()
] with Plavix.
Down 50% from its high, with a CEO buying shares hand-over-fist, SGP is Cramer’s definitive pick for next week – Fed cut or not.
Jim's charitable trust owns Schering-Plough and Altria.
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website?



